Literature DB >> 17237536

Quantum dots for in vivo molecular and cellular imaging.

Xiaohu Gao1, Leland W K Chung, Shuming Nie.   

Abstract

Multifunctional nanoparticle probes based on semiconductor quantum dots (QDs) are developed for simultaneous targeting and imaging of cancer cells in living animals. The structural design involves encapsulating luminescent QDs with an ABC triblock copolymer, and linking this polymer to tumor-targeting ligands, such as antibodies and drug-delivery functionalities. In vivo targeting studies of human prostate cancer growing in nude mouse show that the QD probes can be delivered to tumor sites by both enhanced permeation and retention (passive targeting) and by antibody binding to cancer-specific cell surface biomarkers such as prostate-specific membrane antigen (active targeting). Using both subcutaneous injection of QD-tagged cancer cells and the systemic injection of multifunctional QD probes, multicolor fluorescence imaging of as few as 10-100 cancer cells can be achieved under in vivo conditions. The use of spectrally resolved imaging can efficiently remove autofluorescence background and precisely delineate weak spectral signatures in vivo. These results suggest that QD probes and spectral imaging can be combined for multiplexed imaging and detection of genes, proteins, and small-molecule drugs in single living cells, and that this imaging modality can be adopted for real-time visualization of cancer cell metastasis in live animals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237536     DOI: 10.1385/1-59745-369-2:135

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

Review 1.  Detecting and treating cancer with nanotechnology.

Authors:  Keith B Hartman; Lon J Wilson; Michael G Rosenblum
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

2.  EMT and MET in carcinoma--clinical observations, regulatory pathways and new models.

Authors:  Erik W Thompson; Elizabeth D Williams
Journal:  Clin Exp Metastasis       Date:  2008-06-20       Impact factor: 5.150

3.  Noninvasive molecular imaging of small living subjects using Raman spectroscopy.

Authors:  S Keren; C Zavaleta; Z Cheng; A de la Zerda; O Gheysens; S S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

Review 4.  Advances in fluorescent-image guided surgery.

Authors:  Mark J Landau; Daniel J Gould; Ketan M Patel
Journal:  Ann Transl Med       Date:  2016-10

5.  Fluorescence Determination of Warfarin Using TGA-capped CdTe Quantum Dots in Human Plasma Samples.

Authors:  A Dehbozorgi; J Tashkhourian; S Zare
Journal:  J Fluoresc       Date:  2015-10-19       Impact factor: 2.217

6.  A comparison between time domain and spectral imaging systems for imaging quantum dots in small living animals.

Authors:  Adam de la Zerda; Sunil Bodapati; Robert Teed; Meike L Schipper; Shay Keren; Bryan R Smith; Johnny S T Ng; Sanjiv Sam Gambhir
Journal:  Mol Imaging Biol       Date:  2009-12-10       Impact factor: 3.488

Review 7.  Nanomedicine--challenge and perspectives.

Authors:  Kristina Riehemann; Stefan W Schneider; Thomas A Luger; Biana Godin; Mauro Ferrari; Harald Fuchs
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

8.  Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting.

Authors:  Kai Chen; Jin Xie; Hengyi Xu; Deepak Behera; Mark H Michalski; Sandip Biswal; Andrew Wang; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2009-09-20       Impact factor: 12.479

9.  Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?

Authors:  Maha Saad; Olga B Garbuzenko; Elizabeth Ber; Pooja Chandna; Jayant J Khandare; Vitaly P Pozharov; Tamara Minko
Journal:  J Control Release       Date:  2008-06-25       Impact factor: 9.776

Review 10.  Molecular imaging of prostate cancer: a concise synopsis.

Authors:  Hossein Jadvar
Journal:  Mol Imaging       Date:  2009 Mar-Apr       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.